Shannon Weber discusses with AVAC’s Mitchell Warren the new data presented at CROI 2015 in Seattle, WA, in particular the language we use with non-daily dosing of the HIV prevention pill Truvada. Additionally, he explains what is next for women and PrEP and why the Partners’ Demonstration project integrated treatment and prevention success is so promising for women. For more on AVAC’s important work visit www.AVAC.org